Projects

We have done a chemoinformatics analysis of more than 400,000 chemical compounds tested against human influenza A and B viruses, in which we showed the distribution of various chemical and physicochemical properties in relation to the antiviral activity of the compounds. We also identified compounds that demonstrated activity against the virus, but whose derivatives remain unstudied and therefore may serve as subjects for future research. We have also submitted another manuscript describing a new ...

Currently we are studying MAPK kinase inhibitors as potential antiviral therapeutics. We studied the antiviral activity of six inhibitors of various kinases—cobimetinib, binimetinib, ravoxertinib, tomivosertib, MCP110, and BIX02189—against human influenza virus. We demonstrated that the MNK1/2 kinase inhibitor tomivosertib reduces the replication of influenza A and B viruses in competent MDCK cells at concentrations of 50 and 100 µM

An increasing number of countries are investing efforts to exploit the human genome, in order to improve genetic diagnostics and to pave the way for the integration of precision medicine into health systems. The expected benefits include improved understanding of normal and pathological genomic variation, shorter time-to-diagnosis, cost-effective diagnostics, targeted prevention and treatment, and research advances. Despite the significance of such studies, there is a lack of comprehensive genomic ...

We invite you to take part in the Annual Scientific and Practical Conference of the Interregional Public Organization of Molecular Geneticists in Oncology and Oncohematology (IPO MGO)

“Molecular Diagnostics in Oncology and Related Fields of Medicine,” which will be held on January 17–18, 2026, in Yerevan, Armenia.

The first IPO MGO conference was held in Yekaterinburg in 2022, the second in Saint Petersburg in 2023, and the third in Nizhny Novgorod in 2024. Each event brought together a large ...

The “Low dose radiation risks: present research and future perspectives” Advanced Research Workshop is a NATO (North Atlantic Treaty Organization)-sponsored workshop organized by the McMaster University (Canada) and Institute of Molecular Biology NAS RA (National Academy of Sciences of Republic of Armenia) which offers a unique opportunity to learn about new discoveries and exchange experience with professionals in the field of radioecology, radiobiology, country-specific regulatory agencies, ...

We are pleased to invite your specialists to the International Summit in Immuno-Oncology, which will take place in Yerevan, Armenia, on October 16–18, 2025, organized by Santé Arménie in collaboration with Inserm, the Armenian Association of Clinical Pathologists and Cytologists, and the Institute of Molecular Biology.

This summit marks the beginning of an ambitious effort to establish a world-class immuno-oncology ecosystem in Armenia. We are gathering leading experts in cancer research, clinical ...